Company Filing History:
Years Active: 2025
Title: The Innovations of Matthew Schram
Introduction
Matthew Schram is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of mobile health technology, particularly in the area of electrocardiogram (ECG) sensors. His work focuses on improving heart health monitoring through innovative devices.
Latest Patents
Matthew Schram holds a patent for a groundbreaking invention titled "Two-lead QT interval prediction." This patent describes a mobile electrocardiogram (ECG) sensor that includes an electrode assembly capable of sensing heart-related signals when in contact with a user's body. The device produces electrical signals that represent these sensed signals. Additionally, the ECG sensor features a processing device that is operatively coupled to the electrode assembly. This processing device provides the sensed heart-related signals to a machine learning module, which is trained to predict a twelve-lead QT interval (QTc) value using less than twelve leads. The entire system is housed in a compact design that integrates both the electrode assembly and the processing device.
Career Highlights
Matthew Schram is currently associated with AliveCor, Inc., a company known for its innovative health technology solutions. His work at AliveCor focuses on developing advanced ECG monitoring devices that empower users to take charge of their heart health. His contributions have been instrumental in advancing the capabilities of mobile health technologies.
Conclusion
Matthew Schram's innovative work in the field of mobile ECG sensors exemplifies the potential of technology to enhance health monitoring. His patent for the two-lead QT interval prediction is a testament to his commitment to improving heart health through innovation.